ES2170654A1 - Perfeccionamientos introducidos en el objeto de la patente p9900757, por un procedimiento para la obtencion de gammaglobulinas de origen animal y aplicaciones correspondientes. - Google Patents
Perfeccionamientos introducidos en el objeto de la patente p9900757, por un procedimiento para la obtencion de gammaglobulinas de origen animal y aplicaciones correspondientes.Info
- Publication number
- ES2170654A1 ES2170654A1 ES200000933A ES200000933A ES2170654A1 ES 2170654 A1 ES2170654 A1 ES 2170654A1 ES 200000933 A ES200000933 A ES 200000933A ES 200000933 A ES200000933 A ES 200000933A ES 2170654 A1 ES2170654 A1 ES 2170654A1
- Authority
- ES
- Spain
- Prior art keywords
- mixture
- gamma globulin
- preparation
- animal origin
- plasma proteins
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
Perfeccionamientos introducidos en el objeto de la Patente P9900757, por un procedimiento para la obtención de gammaglobulinas de origen animal y aplicaciones correspondientes, que consisten en una aplicación de una mezcla de proteínas plasmáticas con un contenido en gammaglobulina superior al 25% en peso para la preparación de composiciones medicamentosas, preparados alimenticios y dietéticos: [a] aptos para la prevención y tratamiento de enfermedades gastrointestinales en humanos y animales, [b] aptos para la mejora del estado inmunológico en humanos y animales, [c] aptos para el tratamiento de procesos de malabsorción en humanos y animales, y [d] aptos para el tratamiento de situaciones clínicas que cursan con desnutrición en humanos y animales.
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES00500066T ES2243223T3 (es) | 1999-04-13 | 2000-04-12 | Aplicaciones de mezclas de proteinas plasmaticas de origen animal en gammaglobulinas y procedimiento para su preparacion. |
AT00500066T ATE300956T1 (de) | 1999-04-13 | 2000-04-12 | Anwendung und herstellungsverfahren von tierischen gammaglobulin-reichen plasmaprotein mischungen |
DE60021644T DE60021644D1 (de) | 1999-04-13 | 2000-04-12 | Anwendung und Herstellungsverfahren von tierischen Gammaglobulin-reichen Plasmaprotein Mischungen |
EP00500066A EP1044690B1 (en) | 1999-04-13 | 2000-04-12 | Applications of gamma globulin-rich plasma protein mixtures of animal origin and process for the preparation thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES9900757A ES2158776B1 (es) | 1999-04-13 | 1999-04-13 | Procedimiento para la obtencion de gammaglobulinas de origen animal y aplicaciones correspondientes. |
Publications (2)
Publication Number | Publication Date |
---|---|
ES2170654A1 true ES2170654A1 (es) | 2002-08-01 |
ES2170654B1 ES2170654B1 (es) | 2003-06-16 |
Family
ID=8308004
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES9900757A Expired - Fee Related ES2158776B1 (es) | 1999-04-13 | 1999-04-13 | Procedimiento para la obtencion de gammaglobulinas de origen animal y aplicaciones correspondientes. |
ES200000933A Expired - Fee Related ES2170654B1 (es) | 1999-04-13 | 2000-04-11 | Perfeccionamientos introducidos en el objeto de la patente p9900757, por un procedimiento para la obtencion de gammaglobulinas de origen animal y aplicaciones correspondientes. |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES9900757A Expired - Fee Related ES2158776B1 (es) | 1999-04-13 | 1999-04-13 | Procedimiento para la obtencion de gammaglobulinas de origen animal y aplicaciones correspondientes. |
Country Status (1)
Country | Link |
---|---|
ES (2) | ES2158776B1 (es) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0064210A1 (en) * | 1981-05-01 | 1982-11-10 | Miles Inc. | Oral pharmaceutical composition containing immune globulin |
EP0338229A1 (de) * | 1988-04-19 | 1989-10-25 | Biotest Pharma Gmbh | Präparat mit Antikörperaktivität und breitem Wirkungsspektrum, daraus bestehende oder diese enthaltende Mittel und deren Verwendung zur Behandlung von bakteriell oder toxin-bedingten Erkrankungen und zur Bekämpfung von Protozoen |
US5122373A (en) * | 1983-03-16 | 1992-06-16 | Immuno Aktiengesellschaft | Immunoglobulin-g-containing fraction |
US5531989A (en) * | 1994-10-28 | 1996-07-02 | Metagenics, Inc. | Immunoglobulin and fiber-containing composition for human gastrointestinal health |
WO1999064462A1 (en) * | 1998-06-09 | 1999-12-16 | Statens Serum Institut | Process for producing immunoglobulins for intravenous administration and other immunoglobulin products |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2672303B2 (ja) * | 1987-06-22 | 1997-11-05 | 財団法人 化学及血清療法研究所 | 馬用感染予防治療剤 |
JP2613409B2 (ja) * | 1987-11-20 | 1997-05-28 | 株式会社ミドリ十字 | 抗エイズウイルス抗体陽性静注用免疫グロブリン製剤の製造方法 |
-
1999
- 1999-04-13 ES ES9900757A patent/ES2158776B1/es not_active Expired - Fee Related
-
2000
- 2000-04-11 ES ES200000933A patent/ES2170654B1/es not_active Expired - Fee Related
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0064210A1 (en) * | 1981-05-01 | 1982-11-10 | Miles Inc. | Oral pharmaceutical composition containing immune globulin |
US5122373A (en) * | 1983-03-16 | 1992-06-16 | Immuno Aktiengesellschaft | Immunoglobulin-g-containing fraction |
EP0338229A1 (de) * | 1988-04-19 | 1989-10-25 | Biotest Pharma Gmbh | Präparat mit Antikörperaktivität und breitem Wirkungsspektrum, daraus bestehende oder diese enthaltende Mittel und deren Verwendung zur Behandlung von bakteriell oder toxin-bedingten Erkrankungen und zur Bekämpfung von Protozoen |
US5531989A (en) * | 1994-10-28 | 1996-07-02 | Metagenics, Inc. | Immunoglobulin and fiber-containing composition for human gastrointestinal health |
WO1999064462A1 (en) * | 1998-06-09 | 1999-12-16 | Statens Serum Institut | Process for producing immunoglobulins for intravenous administration and other immunoglobulin products |
Also Published As
Publication number | Publication date |
---|---|
ES2170654B1 (es) | 2003-06-16 |
ES2158776A1 (es) | 2001-09-01 |
ES2158776B1 (es) | 2002-03-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GEP19981289B (en) | Method for Preparing Preserved Medicinal Means Containing Human Protein and Medicinal Means | |
AU561016B2 (en) | N-glycosylated carboxamide derivatives | |
WO1998026747A3 (en) | Superantigen based methods and compositions for treatment of diseases | |
BG109311A (en) | PHARMACEUTICAL COMPOSITION, INCLUDING HUMAN ANTIBODIES CONNECTING HUMAN TNFAL, AND HIS APPLICATION | |
EP0909814A3 (en) | Use of protein kinases for the diagnosis and treatment of Alzheimer's disease | |
IL112665A (en) | 5-Substituted derivatives of mycophenolic acid their preparation and pharmaceutical compositions containing them | |
BR9712259A (pt) | Colostrininin, uso do mesmo, processos de tratar distúrbios do sistema nervoso central e/ou do sistema imune, de preparar colostrinin de colostro de mamìferos e de produzir uma composição farmacêutica, composição farmacêutica, suplemento dietético, nanopeptìdeo, e, uso do mesmo. | |
PT914114E (pt) | Metodos de tratamento de hipersensibilidade de tipo i utilizando monofosforil lipido a | |
WO1995019435A3 (en) | T cell antigen receptor v region proteins and methods of preparation thereof | |
IE871967L (en) | Binding-factor-related polypeptides | |
WO1999014241A3 (en) | Compositions and methods for the treatment of immune related diseases | |
DE3584775D1 (de) | Zusammensetzung zur behandlung von an haemophilia-a-inhibitor leidenden kranken. | |
BE900012A (fr) | Nouveau peptide. | |
CA2142277A1 (en) | Anti-Cancer Therapeutic Compositions for Prophylaxis or for Treatment of Cancer | |
ES2158776A1 (es) | Procedimiento para la obtencion de gammaglobulinas de origen animal y aplicaciones correspondientes. | |
WO2001040465A3 (en) | Compositions and methods for the treatment of immune related diseases | |
EP0955366A4 (en) | ANTIGENIC PROTEIN FROM MALASSEZIA | |
EP0642333A4 (en) | METHOD AND COMPOSITION FOR THE TREATMENT OF DISORDERS ASSOCIATED WITH IMMUNOLOGICAL DYSFUNCTION. | |
DE60021644D1 (de) | Anwendung und Herstellungsverfahren von tierischen Gammaglobulin-reichen Plasmaprotein Mischungen | |
WO2000015797A3 (en) | Compositions and methods for the treatment of immune related diseases | |
WO1998011246A3 (en) | ENDO-β-GALACTOSIDASE | |
Harrison et al. | The physiological breakdown of C3b | |
WO2001016319A3 (en) | Compositions and methods for the treatment of immune related diseases | |
WO2001066740A3 (en) | Compositions and methods for the treatment of immune related diseases | |
Kolberg et al. | Immunoblotting detection of lectins in gluten and white rice flour |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EC2A | Search report published |
Date of ref document: 20020801 Kind code of ref document: A1 Effective date: 20020801 |
|
FG2A | Definitive protection |
Ref document number: 2170654B1 Country of ref document: ES |
|
FD1A | Patent lapsed |
Effective date: 20100312 |